Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. PASW
PASW logo

PASW Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.153
Open
0.150
VWAP
0.15
Vol
211.65K
Mkt Cap
18.79M
Low
0.141
Amount
31.46K
EV/EBITDA(TTM)
--
Total Shares
124.55M
EV
4.86M
EV/OCF(TTM)
--
P/S(TTM)
--
Ping An Biomedical Co Ltd, formerly known as Majestic Ideal Holdings Ltd, is an investment holding company mainly engaged in the provision of apparel supply chain management services (SCM services). The Company operates its business through two segments. The Sales of Yarns segment is mainly engaged in the provision of yarn products, textiles and other products. The Sales of Finished Garments segment is mainly engaged in the provision of finished garments. The Company provides end-to-end supply chain solutions. The Company provides services covering functions within the supply chain of these products, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management.
Show More

Events Timeline

(ET)
2026-02-13
17:00:00
Ping An Biomedical Files to Sell 13.61M Ordinary Shares
select
2026-01-09 (ET)
2026-01-09
09:40:00
Ping An Biomedical Enters Investment Memorandum with Future Biotechnology Group
select
2026-01-09
07:20:00
Ping An Biomedical Enters Share Purchase Agreements with Multiple Investors
select
2025-11-28 (ET)
2025-11-28
06:02:38
Ping An Biomedical Co. Issues Letter Regarding Nasdaq Minimum Bid Price Deficiency
select

News

Benzinga
2.0
02-17Benzinga
ZIM Integrated Shipping Shares Surge 38.1% in Pre-Market Trading
  • Significant Price Surge: ZIM Integrated Shipping shares jumped 38.1% to $30.65 in pre-market trading, indicating strong market optimism regarding its future performance, which may attract more investor interest.
  • Positive Market Reaction: This notable price fluctuation reflects investor confidence in the company's potential growth and profitability, potentially leading to further increases in subsequent trading days and enhancing its market position.
  • Industry-Wide Impact: The surge in ZIM's stock price could influence investor sentiment across the shipping industry, prompting fluctuations in the stock prices of other related companies and affecting overall industry performance.
  • Increased Investor Attention: As the stock price rises, ZIM may attract more attention from analysts and investors, further driving its market performance and trading volume, thereby strengthening the company's competitiveness in the shipping market.
Benzinga
8.5
01-13Benzinga
Heritage Global Inc (HGBL) Acquires Debt Exchange Assets, Shares Surge 19.1%
  • Significant Stock Surge: Heritage Global Inc's shares rose 19.1% to $1.62 in pre-market trading, reflecting strong market confidence in the company's growth potential following the acquisition announcement.
  • Acquisition Details: The company's subsidiary, Heritage DebtX, acquired substantially all assets of The Debt Exchange, which not only strengthens its asset base but also enhances its competitive position in the debt trading market.
  • Strong Market Reaction: The acquisition news generated significant investor interest, with Heritage Global's stock performing notably well in pre-market trading, indicating market approval of its strategic direction.
  • Future Growth Potential: This acquisition positions Heritage Global to capture a larger market share in debt management and trading, potentially leading to long-term revenue growth and business expansion opportunities.
Benzinga
2.0
01-12Benzinga
Dow Jones Falls Over 250 Points as Financial Stocks Decline
  • Market Decline: The Dow Jones index fell over 250 points after market opening on Monday, down 0.61% to 49,202.71, indicating investor concerns about economic outlook which may affect overall market confidence.
  • Weakness in Financial Stocks: Financial stocks dipped by 1% during Monday's trading, reflecting a decline in market confidence in the financial sector, which could lead to capital outflows and increased market volatility.
  • Envirotech Vehicles Surge: Envirotech Vehicles Inc saw its shares soar by 155% to $1.18, indicating strong market optimism about its growth potential, which may attract further investor interest.
  • Atara Biotherapeutics Plummets: Atara Biotherapeutics Inc's shares dropped 54% to $6.24 after receiving an FDA Complete Response Letter citing concerns over clinical trial adequacy, potentially leading to significant financial and operational challenges for the company.
Benzinga
8.5
01-12Benzinga
Bark Inc (BARK) Shares Surge 19.9% on Acquisition Proposal from Great Dane
  • Acquisition Proposal: Great Dane's submission of a non-binding acquisition letter to Bark Inc has led to a 19.9% surge in Bark's pre-market share price to $0.74, indicating strong market enthusiasm for the potential acquisition.
  • Market Reaction: The significant rise in Bark Inc's stock price reflects investor optimism regarding the company's future, which may also attract more investor attention and enhance market liquidity for the stock.
  • Industry Dynamics: In pre-market trading, Signing Day Sports Inc saw a 43.7% increase, while Ping An Biomedical Co Ltd rose 34.3%, highlighting strong market interest in the biotech and sports sectors, which could influence Bark Inc's market positioning.
  • Investor Confidence: The rebound in Bark Inc's stock price may bolster investor confidence in the company, especially after recent market volatility, as the acquisition proposal provides new momentum for future growth.
Globenewswire
7.5
01-09Globenewswire
Ping An Bio Invests $60M in Future Biotechnology Group
  • Strategic Investment: Ping An Bio has signed a non-binding investment memorandum with Future Biotechnology Group, committing an initial cash investment of $30 million and a total of $60 million for subsequent acquisitions, reflecting strong confidence in the biopharmaceutical sector.
  • Performance Targets: Future Biotechnology Group must achieve audited revenues of at least RMB 750 million in 2026, RMB 1.3 billion in 2027, and RMB 2.3 billion in 2028, aligning investment returns with the company's long-term development strategy.
  • Technology Integration: Focused on biopharmaceutical R&D and AI intelligent manufacturing, Future Biotechnology Group will enhance R&D efficiency and industrial capabilities through collaboration with Ping An Bio, strengthening market competitiveness.
  • Industry Outlook: Amid the biopharmaceutical industry's shift towards high-quality development, this investment lays a solid foundation for Ping An Bio's continued expansion in the sector, unlocking long-term growth potential.
Globenewswire
8.5
01-09Globenewswire
Ping An Bio Secures Strategic Investments from Key Industry Leaders to Enhance R&D Capabilities
  • Strong Investor Lineup: Ping An Bio has entered into share purchase agreements with Yao Jinbo of 58 Group, Wang Donghui of Amiba Capital, and Li Daxue of Magcloud Group, further strengthening the company's long-term development potential in biopharmaceutical R&D and medical technology.
  • Yao Jinbo's Strategic Insight: As a representative figure in China's internet sector, Yao's investment serves not only as financial backing but also as a strong endorsement of Ping An Bio's technology commercialization capabilities, showcasing his forward-looking judgment in the biopharmaceutical space.
  • Wang Donghui's Value Investment: Wang Donghui of Amiba Capital emphasizes the importance of R&D capabilities, and his investment in Ping An Bio reflects recognition of the company's technology implementation capabilities and long-term growth potential, helping the company stand out in a competitive market.
  • Li Daxue's Industry Perspective: The involvement of former JD.com Vice President Li Daxue signifies strong capital market recognition of Ping An Bio's transition from technological innovation to industrialization, further solidifying the company's unique position within the biopharmaceutical industry.

Valuation Metrics

The current forward P/E ratio for Ping An Biomedical Co Ltd (PASW.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Ping An Biomedical Co Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

bullish stocks under $1.10
Intellectia · 423 candidates
Price: $0.00 - $1.10
Ticker
Name
Market Cap$
top bottom
CNEY logo
CNEY
CN Energy Group Inc
4.51M
WORX logo
WORX
Scworx Corp
3.80M
MTNB logo
MTNB
Matinas BioPharma Holdings Inc
4.61M
SCNI logo
SCNI
Scinai Immunotherapeutics Ltd
3.47M
PN logo
PN
Skycorp Solar Group Ltd
15.51M
FBLG logo
FBLG
Fibrobiologics Inc
26.61M
stock under 5$ bulish for tomorrow
Intellectia · 447 candidates
Price: <= $5.00
Ticker
Name
Market Cap$
top bottom
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.70M
ZJYL logo
ZJYL
Jin Medical International Ltd
19.82M
WCT logo
WCT
Wellchange Holdings Co Ltd
22.89M
PASW logo
PASW
Ping An Biomedical Co Ltd
3.72M
JOB logo
JOB
GEE Group Inc
23.64M
UGRO logo
UGRO
urban-gro Inc
3.53M
high volume stocks under $1
Intellectia · 97 candidates
Price: <= $1.00Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
AMZE logo
AMZE
Amaze Holdings Inc
11.23M
ASST logo
ASST
Strive Inc
1.11B
DVLT logo
DVLT
Datavault AI Inc
433.82M
MTEN logo
MTEN
Mingteng International Corp Inc
5.55M
IOBT logo
IOBT
IO Biotech Inc
14.94M
BURU logo
BURU
NUBURU Inc
77.15M
stocks under $1 to daytrade today
Intellectia · 15 candidates
Price: <= $1.00Relative Vol: >= 1.50Weekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
TRX logo
TRX
TRX Gold Corp
271.29M
BRCC logo
BRCC
BRC Inc
247.13M
RXT logo
RXT
Rackspace Technology Inc
204.93M
HUMA logo
HUMA
Humacyte Inc
189.14M
ATCH logo
ATCH
Atlasclear Holdings Inc
36.30M
COSM logo
COSM
Cosmos Health Inc
19.42M
day trade stocks under $1 today
Intellectia · 15 candidates
Price: <= $1.00Relative Vol: >= 1.50Weekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
TRX logo
TRX
TRX Gold Corp
271.29M
BRCC logo
BRCC
BRC Inc
247.13M
RXT logo
RXT
Rackspace Technology Inc
204.93M
HUMA logo
HUMA
Humacyte Inc
189.14M
ATCH logo
ATCH
Atlasclear Holdings Inc
36.30M
COSM logo
COSM
Cosmos Health Inc
19.42M
More stocks less than .30 cents
Intellectia · 3 candidates
Price: <= $0.30Relative Vol: >= 1.50Weekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
ATCH logo
ATCH
Atlasclear Holdings Inc
36.30M
IOBT logo
IOBT
IO Biotech Inc
14.94M
PASW logo
PASW
Ping An Biomedical Co Ltd
3.72M

Whales Holding PASW

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Ping An Biomedical Co Ltd (PASW) stock price today?

The current price of PASW is 0.1509 USD — it has increased 2.03

What is Ping An Biomedical Co Ltd (PASW)'s business?

Ping An Biomedical Co Ltd, formerly known as Majestic Ideal Holdings Ltd, is an investment holding company mainly engaged in the provision of apparel supply chain management services (SCM services). The Company operates its business through two segments. The Sales of Yarns segment is mainly engaged in the provision of yarn products, textiles and other products. The Sales of Finished Garments segment is mainly engaged in the provision of finished garments. The Company provides end-to-end supply chain solutions. The Company provides services covering functions within the supply chain of these products, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management.

What is the price predicton of PASW Stock?

Wall Street analysts forecast PASW stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PASW is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Ping An Biomedical Co Ltd (PASW)'s revenue for the last quarter?

Ping An Biomedical Co Ltd revenue for the last quarter amounts to 2.78 USD, decreased -55.02

What is Ping An Biomedical Co Ltd (PASW)'s earnings per share (EPS) for the last quarter?

Ping An Biomedical Co Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does Ping An Biomedical Co Ltd (PASW). have?

Ping An Biomedical Co Ltd (PASW) has 7 emplpoyees as of March 09 2026.

What is Ping An Biomedical Co Ltd (PASW) market cap?

Today PASW has the market capitalization of 18.79M USD.